Guideline: Page 4

Cancer group recommends 9 ways to boost cancer screenings
By LabPulse.com staff writers
The new report, "Responding to the COVID-19 Pandemic: Improving Cancer Screening and Care in the U.S.," aims to address the number of patients who have missed baseline cancer screenings due to the pandemic.
February 15, 2022
2019 04 05 16 58 5171 Cancer Cell 400
Bio-Techne touts study with ExoDx prostate test
By LabPulse.com staff writers
In men with an EPI score below 15.6, the test could prevent those at low risk from proceeding to radical prostatectomy, according to a study published January 27 in the World Journal of Urology.
February 15, 2022
2019 10 16 20 31 7121 Cancer Cells Prostate 400
AMP names new editor in chief for its journal
By LabPulse.com staff writers
Przygodzki will be replacing Barbara Zehnbauer, PhD, who has been the journal's EIC since January 2015. APM said that Zehnbauer "served with distinction" during her tenure as EIC. In 2020, the journal had an impact factor of 5.568 and its most recent CiteScore in 2020 is 8.0.
February 13, 2022
2022 02 11 17 09 1859 Magazine Stack 400
Presidential panel sounds alarm on gaps in cancer screening
By Kate Madden Yee
Underutilization of cancer screening is a serious problem, wrote Dr. John Williams of George Mason University in Gainesville, VA; Dr. Edith Mitchell of Thomas Jefferson University in Philadelphia; and Robert Ingram of Hatteras Venture Partners in Durham, NC, in a letter to President Joe Biden included in the report.
February 3, 2022
2022 02 03 23 16 6543 Cancer Magnifying Glass 400
Natera touts study results on Panorama prenatal test
By LabPulse.com staff writers
The details of the trial named the SNP-based Microdeletion and Aneuploidy RegisTry (SMART) study was published on January 13 in the American Journal of Obstetrics and Gynecology. The study tested the ability of noninvasive prenatal testing (NIPT) to detect genetic abnormalities in fetuses.
January 20, 2022
2019 04 19 17 00 9820 Fetus Mri 400
Study recommends screening for adults at risk of multiple myeloma
By Leah Sherwood
"We know that in cancers such as breast cancer and lung cancer screening, early detection and early intervention can make a difference in patient survival," senior author Dr. Irene Ghobrial of the Dana-Farber Cancer Institute in Boston said in a statement. "We have shown for the first time that with highly sensitive screening techniques, it may eventually be possible to make a difference in the survival of people at elevated risk for multiple myeloma."
December 10, 2021
2021 12 10 19 28 1244 Ash 2021 Sign 400
FDA tightens policy on reviews of lab-developed tests
By Brian Casey
In a November 15 press release, the FDA said it was withdrawing its policy that directed the agency to not enforce premarket review requirements for LDTs. The agency said it was taking the action to "help ensure that COVID-19 tests are accurate and reliable."
November 14, 2021
2020 03 18 20 13 7386 Virus Coronavirus Covid 19 400
PSA testing rebounds after U.S. task force reverses guidance
By Joseph Constance
PSA testing grew at a 12.5% relative increase for men ages 40 to 89 from 2016 to 2019, according to a large national cohort study of over 8 million privately insured men. Significant increases in testing were seen among patients 55 to 69 years, for whom screening is specified by the guideline. But testing also grew in men ages 40 to 54 years, and among those 70 years or older, for whom routine PSA screening is not recommended.
November 14, 2021
2021 11 13 00 11 7867 Diagnostic Test Sample Psa Prostate 400
Could scientists have better communicated about COVID-19?
By Leah Sherwood
In his talk, Thorp addressed a number of topics related to the public role of Science and other top peer-reviewed journals, including its response to COVID-19, the role of preprints of scientific papers, strategies for better communication concerning science, and the role of social media in public scientific discourse.
September 28, 2021
2021 09 29 19 28 2325 Aacc 2021 400
MiR Scientific touts data on prostate cancer liquid biopsy
By LabPulse.com staff writers
MiR Sentinel was able to make the determination from a single urine sample, according to the company. Also, these new data validate a study that was published in September 2020 in the Journal of Urology, the company noted.
September 19, 2021
2021 02 13 00 35 3916 Prostate Cancer 400
USPSTF: Evidence weak for screening men for chlamydia, gonorrhea
By Leah Sherwood
The latest recommendations apply to asymptomatic, sexually active adolescents and adults, including those who are pregnant. The task force concluded with moderate certainty that there was a moderate net benefit to screen for chlamydia and gonorrhea in all sexually active women 24 years or younger and in women 25 years or older who are at increased risk for infection. However, for men it did not issue a screening recommendation.
September 15, 2021
2019 05 24 21 56 3410 Gonorrhea Neisseria Gonorrhoeae 400
New blood test for prostate cancer screening reduces MRI
By Kate Madden Yee
The findings could translate to better prostate cancer screening, said study contributing author Martin Eklund, PhD, of the Karolinska Institute in Stockholm, in a statement released by the institute. The research team was led by Dr. Tobias Nordström, PhD, also of Karolinska.
August 12, 2021
2019 04 22 18 53 8505 Lab Blood Liquid Samples 400
Previous Page
Page 4 of 9
Next Page